v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ 29,055 $ (8,973) [1]
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 12,747 9,905 [1]
Amortization of debt issuance cost 440 332 [1]
Deferred taxes 5,415 (5,764) [1]
Stock-based compensation 4,581 3,522 [1]
Impairment and loss on sale of business segments 0 33,952 [1]
Loss on sale of property and equipment 3 10 [1]
Gain on settlement of corporate-owned life insurance (357) 0 [1]
Interest income on note receivable (694) 0 [1]
Changes in operating assets and liabilities, net of impact of acquisitions:    
Receivables (25,772) (19,393) [1]
Contract assets (4,755) (920) [1]
Inventories (71,544) (6,359) [1]
Prepaid expenses and other current assets and other assets 515 (29,910) [1]
Operating lease assets and liabilities, net 396 372 [1]
Accounts payable and deferred compensation (10,847) (10,892) [1]
Accrued expenses and other liabilities (1,447) (12,514) [1]
Net cash used in operating activities (62,264) (46,632) [1]
Cash flows from investing activities:    
Purchases of property and equipment (6,457) (2,875) [1]
Proceeds from the sale of business segments, net of cash divested 0 2,746 [1]
Cash paid for acquisitions, net of cash acquired (5,391) 0 [1]
Purchases of intangible assets (16,000) 0
Proceeds from Settlement of Corporate Owned Life Insurance 760 0 [1]
Net cash used in investing activities (27,088) (129) [1]
Cash flows from financing activities:    
Borrowings on bank credit facilities 47,273 74,489 [1]
Repayments on bank credit facilities (49,148) (39,989) [1]
Proceeds from issuance of common stock, net 829,457 0 [1]
Proceeds from issuance of tangible equity units, net 445,386 0
Payment of debt financing costs (1,313) 0 [1]
Payment of taxes for equity transactions (8,930) (4,201) [1]
Dividends paid (2,340) (2,060) [1]
Other (984) 0 [1]
Net cash provided by financing activities 1,259,401 28,239 [1]
Net increase (decrease) in cash and cash equivalents 1,170,049 (18,522) [1]
Cash and cash equivalents, beginning of period 69,358 29,030 [1]
Cash and cash equivalents, end of period $ 1,239,407 $ 10,508 [1]
[1]
(a) The cash flows related to discontinued operations and held-for-sale assets and liabilities have not been segregated, and remain included in the major classes of assets and liabilities. Accordingly, the Consolidated Statements of Cash Flows include the results of continuing and discontinued operations. See Note (3) "Discontinued Operations".